SOPH
SOPH
NASDAQ · Health Care

Sophia Genetics Sa

$4.98
+0.01 (+0.20%)
As of Mar 25, 3:16 PM ET ·
Financial Highlights (FY 2026)
Revenue
66.32M
Net Income
-63,595,821
Gross Margin
67.4%
Profit Margin
-95.9%
Rev Growth
+17.2%
D/E Ratio
0.31
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.4% 67.4% 37.1% 37.1%
Operating Margin -102.1% -91.9% 15.7% 15.5%
Profit Margin -95.9% -91.1% 12.0% 14.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 66.32M 56.57M 148.95M 128.31M
Gross Profit 44.71M 38.14M 55.31M 47.64M
Operating Income -67,737,691 -52,003,686 23.40M 19.86M
Net Income -63,595,821 -48,823,883 17.87M 18.85M
Gross Margin 67.4% 67.4% 37.1% 37.1%
Operating Margin -102.1% -91.9% 15.7% 15.5%
Profit Margin -95.9% -91.1% 12.0% 14.7%
Rev Growth +17.2% +17.2% -3.7% -9.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 34.86M 34.86M 123.79M 131.89M
Total Equity 112.03M 112.03M 159.52M 160.29M
D/E Ratio 0.31 0.31 0.78 0.82
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -62,708,438 -50,817,210 34.80M 29.87M
Free Cash Flow 26.94M 20.01M